Metaanalysis of Randomized Trials of the Efficacy and Safety of Donepezil, Galantamine, and Rivastigmine for the Treatment of Alzheimer Disease

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

A new rating scale for Alzheimer's disease

1984 • 3,948 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

A 5-month, randomized, placebo-controlled trial of galantamine in AD

2000 • 911 citations

Galantamine in AD

2000 • 864 citations

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

1998 • 753 citations

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

2002 • 750 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

2000 • 609 citations

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

1999 • 581 citations

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

2001 • 505 citations

Donepezil for dementia due to Alzheimer's disease

2003 • 500 citations

A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

2001 • 362 citations

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

2001 • 273 citations

The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease

1998 • 269 citations

Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease

2001 • 204 citations

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

2000 • 179 citations

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

2000 • 175 citations

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention

1992 • 113 citations

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon®)

1999 • 102 citations

The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials

2000 • 75 citations

Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease

1996 • 74 citations

Efficacy and tolerability of rivastigmine in patients with dementia of the Alzheimer type

1998 • 65 citations